|Chemical and physical data|
|Molar mass||510.4 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|